Risperidone: all 265 studies that test it
Page 2 of 3. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT02186769Phase 1
- Antipsychotic to Treat Psychosis SyndromeStatus unknownNCT02137616Not applicable
- Efficacy and Safety of Risperidone and Trazodone Monotherapy and Combination Therapy in Critically Ill Patients With DeliriumWithdrawnNCT02118688Phase 4
- Bioavailability of LY03004 and Risperdal® Consta®CompletedNCT02091388Phase 1
- Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric ParticipantsCompletedNCT02087579Phase 1
- Methylphenidate vs. Risperidone for the Treatment of Children and Adolescents With ADHD and Disruptive DisordersTerminatedNCT02063945Phase 4
- Pharmacokinetic and Safety Study of LY03004 in Stable Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT02055287Phase 1
- Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction StudyCompletedNCT02051387Phase 1
- The Effect of Sertindole and Risperidone on Endophenotypic Markers of SchizophreniaTerminatedNCT02021201Phase 4
- Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic EpisodeCompletedNCT01977300Phase 3
- Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With PsychosisCompletedNCT01878513Not applicable
- Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose StrengthsCompletedNCT01788774Phase 1
- Impulsivity and Thought Process Disorder in Patients With Active Suicidal Ideation and DepressionWithdrawnNCT01770600Not applicable
- Bioequivalence Study of Risperidone Tablet 1 mg Under Fasting ConditionCompletedNCT01722201Phase 1
- A Study of the Combination of Multiple Doses of RO5285119 With a Single Dose of Risperidone in Healthy VolunteersCompletedNCT01708616Phase 1
- A Study to Evaluate the Efficacy and Safety of Risperidone (R064766) in Children and Adolescents With Irritability Associated With Autistic DisorderCompletedNCT01624675Phase 3
- Bioequivalence Study of Risperidone Tablet 1 mg Under Fed ConditionCompletedNCT01618760Phase 1
- A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five AntipsychoticsCompletedNCT01607762Phase 1
- Evaluation of the Effects of Treatment of Psycho-stimulant and Cannabis-dependent Users in IsraelStatus unknownNCT01510015Not applicable
- Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant DepressionCompletedNCT01282632Phase 1/2
- Typical Versus Atypical Antipsychotics; Occupation of Striatal Receptors and the Appearance of Extrapyramidal Symptomatology, in Healthy VolunteersStatus unknownNCT01259973Phase 1
- Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRICompletedNCT01234454Not applicable
- Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fasting ConditionsCompletedNCT01222975Not applicable
- Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fed ConditionsCompletedNCT01222923Not applicable
- Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult SubjectsCompletedNCT01217918Phase 1
- Risperidone Treatment In Children With Autism Spectrum Disorder And High Levels Of Repetitive BehaviorCompletedNCT01171937Phase 2
- Effects of Ketamine and Risperidone on CognitionCompletedNCT01140620Phase 4
- Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to RisperidoneCompletedNCT01119638Phase 4
- Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fed ConditionCompletedNCT01064271Phase 1
- Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fasting ConditionCompletedNCT01064232Phase 1
- Standard Comprehensive Intervention to Treat First-episode SchizophreniaStatus unknownNCT01057849Not applicable
- Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Plus Low Dose of Haloperidol in the Treatment of SchizophreniaTerminatedNCT00998608Phase 4
- A Pharmacokinetic Study of Risperidone and Topiramate Administered Alone and in Combination in Patients With Bipolar Disorder or Schizoaffective DisordersCompletedNCT00986336Phase 1
- Bioequivalence Study of Risperidone 1 mg Tablets of Torrent Pharmaceuticals Limited, India and Risperdal® (Risperidone) 1 mg Tablets of Janssen Pharmaceutical Products, LP, USA, in Healthy Human Adult Subjects, Under Fed ConditionsCompletedNCT00939926Phase 1
- Bioequivalence Study of Risperidone 1.0 mg Tablets of Torrent Pharmaceuticals Limited., India and Risperdal® (Risperidone) 1.0 mg Tablets of Janssen Pharmaceutical Products, LP, USA, in Healthy Human Adult Subjects, Under Fasting ConditionsCompletedNCT00939497Phase 1
- Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) ScanningStatus unknownNCT00937261Phase 4
- Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic SettingCompletedNCT00932529Phase 4
- Metabolic Effects of Antipsychotic Substitution in ChildrenWithdrawnNCT00910780Phase 2/3
- Effect of Add-on Citalopram to Risperidone on Negative Symptoms in SchizophreniaCompletedNCT00893256Phase 4
- Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in SchizophreniaCompletedNCT00859872Phase 4
- Risperidone Maintenance Treatment in SchizophreniaCompletedNCT00848432Phase 4
- Risperidone 1 mg Tablet in Healthy Subjects Under Fasting ConditionsCompletedNCT00830349Phase 1
- Risperidone 1 mg Tablets Dosed in Healthy Subjects Under Fed ConditionsCompletedNCT00829894Phase 1
- Pharmacological Treatment of Children and Adolescents With Severe Mood DysregulationStatus unknownNCT00825552Not applicable
- Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With SchizophreniaStatus unknownNCT00825045Not applicable
- Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)Status unknownNCT00794625Phase 4
- Liquid Risperidone in the Treatment of Acute Agitation in Psychiatrically Hospitalized ChildrenCompletedNCT00790075Phase 4
- Efficacy Study on Cognitive Functions in Schizophrenic PatientsCompletedNCT00761670Phase 4
- Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet.CompletedNCT00645502Phase 1
- Low-Dose Risperidone Treatment for Subjects Suffering From Borderline Personality DisorderStatus unknownNCT00633802Not applicable
- The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD)Status unknownNCT00626613Phase 4
- A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.CompletedNCT00558298Phase 3
- An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care TreatmentCompletedNCT00526877Phase 4
- Quality of Life (QOL) in Female Patient With SchizophreniaTerminatedNCT00498004Phase 4
- A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.CompletedNCT00495118Phase 3
- Managing Acute Schizophrenia, a Comparison Between Two Atypical AntipsychoticsCompletedNCT00485498Phase 4
- A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic AttacksCompletedNCT00457106Not applicable
- Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSDCompletedNCT00433121Phase 4
- Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.CompletedNCT00399698Phase 3
- A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.CompletedNCT00378183Phase 4
- A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic EpisodeCompletedNCT00378092Phase 4
- Comparison of Applied Behavioral Analysis (ABA) Versus ABA and RisperidoneCompletedNCT00374764Not applicable
- Switch Study of Existing Atypical Antipsychotics to BifeprunoxCompletedNCT00347425Phase 3
- Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or ParkinsonismCompletedNCT00331825Phase 4
- Risperdal Consta and Health Care Utilization in Patients With SchizophreniaCompletedNCT00313391Phase 4
- Risperidone Alone Vs. Risperidone Plus Valproate in the Treatment of Patients With Schizophrenia and HostilityCompletedNCT00308360Phase 4
- Identification and Treatment of the Liability to Develop SchizophreniaStatus unknownNCT00305474Phase 4
- Effect of Quetiapine on Negative Symptoms and CognitionCompletedNCT00305422Phase 3
- SWitching to Abilify Trial (SWAT)CompletedNCT00304616Phase 4
- Risperidone Augmentation for Treatment-Resistant Aggression in ADHDCompletedNCT00297739Phase 4
- Risperidone Plus Mood Stabilizer in Treatment of Mixed ManiaCompletedNCT00294255Phase 4
- Risperidone Augmentation in Patients With SchizophreniaCompletedNCT00289861Phase 4
- Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid MetabolismCompletedNCT00287820Phase 4
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's DiseaseTerminatedNCT00287742Phase 3
- Aripiprazole in the Treatment of Acutely Relapsed Patients With SchizophreniaCompletedNCT00283179Phase 3
- Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety DisorderCompletedNCT00277654Phase 3
- Risperidone LA Heathcare Resource StudyCompletedNCT00272597Phase 4
- CARE Study: Improving Treatment for the Most Severely Ill With SchizophreniaCompletedNCT00272584Phase 4
- A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental RetardationCompletedNCT00266552Phase 3
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Children With Autistic Disorder and Other Pervasive Developmental Disorders (PDD)CompletedNCT00261508Phase 3
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I DisorderCompletedNCT00257075Phase 3
- A Prospective Study of Risperdal (Risperidone) for the Treatment of Behavioral Disorder Following Psychological Therapy for Challenging Behavior in Learning Disabled ChildrenCompletedNCT00254930Phase 3
- Safety and Efficacy of Seroquel in First Episode SchizophreniaCompletedNCT00254241Phase 4
- A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With HaloperidolCompletedNCT00253162Phase 3
- A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar DisorderCompletedNCT00253149Phase 3
- A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With SchizophreniaCompletedNCT00253136Phase 3
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With DementiaCompletedNCT00253123Phase 3
- A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective DisorderCompletedNCT00253110Phase 4
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.CompletedNCT00250367Phase 3
- A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental RetardationCompletedNCT00250354Phase 3
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I DisorderCompletedNCT00249236Phase 3
- A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic PatientsCompletedNCT00249171Phase 4
- A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With DementiaCompletedNCT00249158Phase 3
- A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With DementiaCompletedNCT00249145Phase 3
- A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic SchizophreniaCompletedNCT00249132Phase 3
- A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic SchizophreniaCompletedNCT00249119Phase 3
- A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With SchizophreniaCompletedNCT00246285Phase 3
- An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of RisperdoneCompletedNCT00246272Phase 3
- A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar DisorderCompletedNCT00246246Phase 3
- Side Effects of Newer Antipsychotics in Older AdultsCompletedNCT00245206Phase 4